Submission Details
| 510(k) Number | K953591 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 1995 |
| Decision Date | November 29, 1996 |
| Days to Decision | 486 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K953591 is an FDA 510(k) clearance for the CEP 8 SPECTRUMORANGE DNA PROBE KIT, a Dna-probe Kit, Human Chromosome (Class II — Special Controls, product code OYU), submitted by Vysis (Downers Grove, US). The FDA issued a Cleared decision on November 29, 1996, 486 days after receiving the submission on August 1, 1995. This device falls under the Pathology review panel. Regulated under 21 CFR 866.4700.
| 510(k) Number | K953591 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 1995 |
| Decision Date | November 29, 1996 |
| Days to Decision | 486 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | OYU — Dna-probe Kit, Human Chromosome |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.4700 |
| Definition | Detection Of Alpha Satellite Sequences In The Centromere Regions Of Human Chromosomes In Conjunction With Routine Diagnostic Cytgenetic Testing. It Is Indicated For Use As An Adjunct To Standard Cytogenetic Methaphase Analysis A Identifying And Enumerating Human Chromosomes Via Fluorescence In Situ Hybridization (fish) In Metaphase Cells And Interphase Nuclei Of Human Cells. It Is Not Intended To Be Used As A Stand Alone Assay For Test Reporting Or Clinical Diagnosis. Fish Results Are Intended To Be Reported And Interpreted Only In Conjunction With Results Of Standard Cytogenetic Analysis, Performed Concurrently, Utilizing The Same Patient Specimen. |